# Veterinary Shock: Fluid Resuscitation Strategies ## Key Takeaways - Fluid resuscitation in shock is a cyclical process of assessment, intervention, and reassessment, prioritizing perfusion endpoints (lactate clearance, mucous membrane color, CRT, mentation) over solely blood pressure normalization to ensure adequate tissue oxygenation. - Aggressive fluid administration, particularly in hemorrhagic shock, can be detrimental by diluting clotting factors and increasing hydrostatic pressure at bleeding sites, necessitating a restrained approach and consideration of permissive hypotension. - The choice of resuscitation strategy is dictated by shock classification (hypovolemic, distributive, cardiogenic, obstructive), with hypovolemic and distributive shock generally benefiting from volume expansion, while cardiogenic and obstructive shock require addressing the underlying cause first. - Species-specific adjustments are critical, with cats being more susceptible to volume overload than dogs, and large animals presenting unique challenges related to vascular volume and gastrointestinal physiology. - Over-resuscitation carries significant risks, including pulmonary edema and cerebral inflammation, emphasizing the importance of defined fluid volume ceilings and monitoring for signs of overload such as lung auscultation and central venous pressure trends. - Refractory shock, defined as failure to achieve perfusion endpoints despite adequate volume, mandates a reassessment of the diagnosis and consideration of adjunctive therapies such as vasopressors or inotropes, rather than continued aggressive fluid administration. --- This article provides a practical framework for fluid resuscitation in shock across canine, feline, and large animal patients. It serves the practicing veterinarian who must make rapid decisions about bolus volume, rate, and reassessment intervals while managing the underlying cause of circulatory failure. The content focuses on procedural strategy: how to give fluids, how to monitor response, and when to stop. Specific fluid types, including crystalloid and colloid comparisons, are addressed in a separate article. The clinical question at the center of this reference is straightforward: given a patient in shock, what resuscitation sequence produces the best perfusion with the least harm? The answer requires understanding the physiology of shock states, the limitations of blood pressure as a monitoring endpoint, and the evidence that guides fluid administration. This first part establishes the conceptual foundation. Later parts translate that foundation into step-by-step protocols, species-specific adjustments, and troubleshooting guidance. Resuscitation is not a single event. It is a repeated cycle of assessment, intervention, and reassessment. Each cycle should have a defined endpoint, and the clinician must be willing to stop fluid administration when that endpoint is reached or when the patient fails to respond. The evidence increasingly supports a restrained approach, particularly in hemorrhagic shock, where aggressive fluid administration can worsen outcomes by diluting clotting factors and dislodging formed thrombi. ## At a Glance | Parameter | Clinical Decision Point | Rationale | |---|---|---| | Shock classification | Identify hypovolemic, distributive, cardiogenic, or obstructive | Determines whether fluids are primary therapy or contraindicated | | Initial bolus rate | Rapid administration over 10 to 20 minutes | Matches the speed of circulatory decompensation | | Reassessment interval | After every bolus, before the next one | Detects response or deterioration before additional volume is given | | Blood pressure target | Species-specific minimums, not normalization | Avoids over-resuscitation while ensuring organ perfusion pressure | | Perfusion endpoints | Lactate clearance, mucous membrane color, CRT, mentation | Reflect tissue oxygenation better than pressure alone | | Fluid volume ceiling | Stop when endpoints are met or when volume fails to improve endpoints | Prevents fluid overload and tissue edema | | Monitoring for overload | Lung auscultation, body weight, central venous pressure trends | Identifies complications before they become irreversible | | Refractory shock | Add vasopressors or inotropes after adequate volume | Volume alone cannot correct all shock states | ## Pathophysiology of Shock and the Rationale for Fluid Therapy Shock is a state of inadequate oxygen delivery to tissues relative to metabolic demand. The final common pathway is cellular hypoxia, anaerobic metabolism, and, if uncorrected, cell death and organ failure. Fluid resuscitation aims to restore effective circulating volume and cardiac output so that oxygen delivery meets demand. The four broad categories of shock differ in their fluid requirements. Hypovolemic shock, from hemorrhage, dehydration, or third-space losses, responds to volume replacement because the problem is reduced preload. Distributive shock, including sepsis and anaphylaxis, involves vasodilation and capillary leak, fluids help fill an expanded vascular space but may also leak into tissues. Cardiogenic shock results from pump failure, and aggressive fluids can worsen pulmonary edema. Obstructive shock, from pericardial effusion or tension pneumothorax, requires addressing the obstruction before volume therapy is effective. The body compensates for reduced cardiac output through baroreceptor activation, sympathetic discharge, and neuroendocrine responses. These mechanisms maintain blood pressure at the expense of perfusion to nonessential beds. By the time hypotension is detectable, compensation is failing. This is why blood pressure alone is an inadequate monitoring target. A patient can be in compensated shock with normal pressure but poor tissue perfusion, or in decompensated shock where pressure has finally fallen. ## The Evidence Base for Resuscitation Strategy Experimental work in animal models has shaped current resuscitation practice. A porcine model of hemorrhagic shock compared fluid resuscitation guided by sublingual partial pressure of carbon dioxide with resuscitation guided by blood pressure. The tissue perfusion-guided group required fluid in only 40% of animals and received significantly lower volumes of Ringer's lactate solution without compromising outcomes. This study, published in an institutional journal in 2013, supports the principle that resuscitation should be guided by perfusion markers instead of pressure targets alone. The same principle applies to the choice of monitoring during resuscitation. Ejection fraction, commonly used to assess cardiac function in sepsis, is heavily load-dependent. A 2026 porcine study of endotoxic shock demonstrated that ventricular loading conditions, specifically effective arterial elastance and end-diastolic volume, account for the majority of the variance in ejection fraction, while intrinsic contractility contributes less. For the clinician, this means that changes in ejection fraction during fluid resuscitation may reflect changes in preload instead of changes in cardiac health. Functional hemodynamic monitoring, such as pulse pressure variation or stroke volume variation where available, provides more useful information about fluid responsiveness. ## Perfusion-Guided Resuscitation The shift from pressure-guided to perfusion-guided resuscitation represents a fundamental change in approach. Pressure is easy to measure but late to change. Perfusion markers such as lactate, central venous oxygen saturation, and mucosal carbon dioxide reflect the actual state of tissue oxygenation. Lactate is the most accessible perfusion marker in general practice. It rises when anaerobic metabolism begins and falls as perfusion improves. Serial lactate measurements, instead of a single value, guide resuscitation. A falling lactate indicates that oxygen delivery is improving. A rising or static lactate despite fluid administration suggests either inadequate resuscitation or ongoing tissue injury. Sublingual carbon dioxide monitoring, as used in the porcine model described above, offers a real-time window into tissue perfusion. Elevated sublingual PCO2 indicates poor local blood flow, and normalization indicates restored perfusion. This technique has not yet become standard in veterinary practice but illustrates the direction of the evidence. ## The Risks of Over-Resuscitation Aggressive fluid administration carries its own morbidity. In hemorrhagic shock, large volumes of crystalloid dilute coagulation factors, lower hematocrit, and increase hydrostatic pressure at bleeding sites. The result can be continued hemorrhage and worse outcomes despite apparent hemodynamic improvement. This has driven the concept of controlled or hypotensive resuscitation in trauma patients, where fluids are given to maintain a minimum perfusion pressure instead of to normalize blood pressure. Fluid overload affects other organs as well. The 2021 porcine study of hemorrhagic shock resuscitation compared gelatine-polysuccinate, hydroxyethyl starch, and balanced electrolyte solution for their effects on cerebral integrity. The study measured cerebral inflammation, apoptosis, and blood flow after resuscitation. While the specific findings are detailed in the source, the broader lesson is that resuscitation fluids are not biologically inert. They interact with the brain, kidneys, and vascular endothelium, and the choice of fluid and volume has consequences beyond hemodynamics. ## Species Considerations in Resuscitation Strategy Fluid resuscitation protocols differ across species in ways that reflect underlying physiology. Dogs tolerate rapid bolus administration well and are commonly resuscitated with large volumes delivered over short intervals. Cats are more susceptible to volume overload and require smaller, more carefully monitored boluses. The RECOVER Initiative, which publishes evidence-evaluated consensus guidelines for veterinary CPR, addresses fluid administration in the peri-arrest and post-arrest periods and emphasizes the importance of species-specific dosing. The AAHA and AAFP fluid therapy guidelines for dogs and cats provide consensus guidance on rate planning and complication avoidance in small animal patients. Large animal species present additional challenges. Horses, for example, have large vascular volumes and can require substantial fluid volumes, but they are also prone to gastrointestinal complications from rapid administration. Ruminants have unique fluid and electrolyte considerations related to their digestive physiology. The MSD Veterinary Manual provides species-specific clinical guidance that should be consulted when treating less common patients. ## Monitoring and Endpoints Every resuscitation protocol must define its endpoints before the first bolus is given. The endpoints should be measurable, repeatable, and tied to tissue perfusion instead of to a single vital sign. Heart rate, mucous membrane color, capillary refill time, mentation, pulse quality, and urine output all provide information about perfusion. Lactate adds a biochemical dimension. Blood pressure, measured directly or indirectly, confirms that perfusion pressure is adequate. The reassessment interval is as important as the initial bolus. A common error is to administer fluids, then wait an extended period before rechecking the patient. The correct approach is to reassess immediately after each bolus, then at progressively longer intervals as the patient stabilizes. Each reassessment should answer two questions: has the endpoint been reached, and has the patient developed signs of fluid overload? Refractory shock, defined as failure to reach endpoints despite adequate volume resuscitation, requires a change in strategy. This may mean adding vasopressors or inotropes, reassessing the shock classification, or investigating for ongoing losses. Continuing fluids in a patient who has not responded to volume is a failure mode that must be recognized early. The evidence on arginine vasopressin in hemorrhagic shock, reviewed in a 2012 institutional publication, suggests that pressure-support strategies may reduce the volume of fluid required and improve perfusion pressures in selected patients, though large prospective studies are lacking. ## The Resuscitation Protocol: Structured Bolus Delivery Fluid resuscitation in shock is best executed as a sequence of discrete, observable interventions instead of a continuous infusion. Each bolus is a test of the cardiovascular system's response, and the patient's reaction to that test determines the next action. This framework applies across species, though the volumes and speeds differ substantially. ### Initial Bolus Volume and Rate The initial bolus volume is calculated from the patient's estimated body weight and the suspected shock category. For dogs and cats, the 2024 AAHA/AAFP fluid therapy guidelines recommend starting with a bolus of 15 to 20 mL/kg for crystalloids, delivered over 15 to 20 minutes in most shock states. The same guidelines advise that hypotensive patients or those with severe hypovolemia may require the upper end of this range, while patients with cardiac compromise or suspected volume intolerance should receive the lower end or a reduced rate. For large animal patients, the volume per kilogram is smaller. Adult horses in hypovolemic shock typically receive crystalloid boluses of 10 to 20 mL/kg administered rapidly, but total volumes are limited by practical constraints of delivery rate and the risk of tissue edema. Ruminants tolerate similar volumes but require slower administration to avoid pulmonary edema, particularly in adult cattle where the interstitial space is capacious and fluid redistribution is unpredictable. The delivery method matters as much as the volume. A bolus given over 15 minutes through a peripheral catheter in a 10 kg dog requires a pump or careful manual pressure. In emergency settings where a pump is unavailable, a fluid administration set with a large bore needle and a 60 mL syringe for manual push is an acceptable alternative for the first bolus, though this technique risks rapid administration and should be followed by a slower continuous rate. ### The Reassessment Interval The single most important discipline in fluid resuscitation is the pause. After each bolus, stop the fluid and reassess the patient. The reassessment interval should be short, typically 5 to 10 minutes after the bolus completes, and should include the parameters described in the monitoring section of this article. The decision tree at each reassessment point is straightforward: - If perfusion parameters have normalized, stop bolus therapy and transition to maintenance or replacement rates. - If perfusion parameters have improved but not normalized, repeat the bolus once or twice more, then reassess the total volume delivered. - If perfusion parameters are unchanged or worsened after two boluses, stop crystalloid boluses and reconsider the diagnosis. The patient may have ongoing hemorrhage, a cardiogenic component, or distributive shock requiring vasopressor support instead of additional volume. This staged approach prevents the common failure mode of administering a large total volume before any reassessment occurs. A patient that receives 60 mL/kg of crystalloid without interruption may develop pulmonary edema before the clinician recognizes that the shock is not volume-responsive. ### Total Volume Ceilings The evidence for volume ceilings comes from experimental models. In a porcine model of hemorrhagic shock, fluid resuscitation guided by sublingual partial pressure of carbon dioxide required significantly less Ringer's lactate solution than blood pressure-guided resuscitation, with only 40% of animals in the PCO2-guided group requiring any fluid at all. This finding supports the principle that the minimum effective volume is the correct volume, and that titration against a perfusion-specific endpoint reduces total fluid administered. For dogs and cats, a practical ceiling is 60 to 90 mL/kg of crystalloid within the first hour. If the patient has received this volume and remains in shock, additional crystalloid boluses are unlikely to help and may cause harm. The clinician should then consider colloids, blood products, or vasopressors depending on the shock category. The AAHA/AAFP guidelines emphasize that crystalloid volumes above this range are associated with increasing complication rates, particularly in patients with concurrent cardiac or renal disease. ## Decision Points That Change the Protocol ### Hemorrhagic Shock In hemorrhagic shock, the resuscitation strategy diverges from other shock categories. The goal is not to restore normal blood pressure but to maintain perfusion at a level that supports organ function while minimizing ongoing blood loss. This concept, often called permissive hypotension, is supported by the porcine data showing that less aggressive fluid administration guided by tissue perfusion markers reduces total volume without compromising outcomes. For the practicing veterinarian, this means accepting a lower mean arterial pressure target in hemorrhagic shock, typically 60 to 70 mmHg in dogs, instead of the 80 to 90 mmHg target used in other shock states. The patient should receive the smallest bolus that maintains consciousness, adequate urine output, and improving lactate or perfusion parameters. Definitive hemorrhage control, whether surgical or through compression, takes priority over continued fluid administration. ### Endotoxic and Septic Shock The hemodynamic profile in endotoxic shock is more complex than simple hypovolemia. A porcine model of endotoxic shock demonstrated that biventricular ejection fraction is primarily determined by loading conditions instead of intrinsic contractility, with effective arterial elastance and end-diastolic volume accounting for the majority of the explained variance in left ventricular ejection fraction. This finding has direct clinical relevance: fluid resuscitation in septic shock should be guided by preload responsiveness, not by ejection fraction or contractility estimates. In practical terms, this means that a septic patient with a low ejection fraction on point-of-care ultrasound may still benefit from additional fluid if the ventricles are underfilled. Conversely, a patient with a normal ejection fraction but high afterload may not respond to further volume. The decision to continue fluids in septic shock should incorporate dynamic parameters such as pulse pressure variation or vena cava collapsibility where available, instead of static measurements. ### The Non-Responder The patient that fails to respond to two or three crystalloid boluses requires a diagnostic pause. The differential for non-response includes ongoing hemorrhage, unrecognized cardiogenic shock, severe vasodilation requiring vasopressors, and iatrogenic volume overload. Point-of-care ultrasound is the most useful single test in this situation, allowing assessment of cardiac filling, contractility, and the presence of free fluid in the thorax or abdomen. If the non-responder has evidence of volume overload, including pulmonary edema or jugular distension, fluid therapy should stop immediately and the clinician should consider diuretics or inotropic support. If the non-responder has ongoing hemorrhage, blood products or surgical intervention are indicated. If the non-responder has severe vasodilation, vasopressor therapy should be initiated while fluid administration continues at a reduced rate. ## Equipment and Consumable Choices The equipment available changes the resuscitation strategy. A patient with a single 20 gauge peripheral catheter in a cephalic vein cannot receive a 20 mL/kg bolus over 15 minutes without significant resistance and catheter failure. The clinician must match the delivery plan to the access available. For small animal patients, an 18 gauge or larger catheter in a cephalic or saphenous vein is adequate for most bolus therapy. Intraosseous access is a reliable alternative in pediatric patients, cats, and small dogs where venous access is difficult. The intraosseous route delivers fluids at rates comparable to peripheral venous access and should be placed early in the resuscitation of a patient with poor vascular access. For large animal patients, a 14 gauge or 12 gauge catheter in the jugular vein is standard for rapid fluid administration. The jugular route is preferred because it allows delivery of large volumes without the risk of thrombophlebitis associated with peripheral catheters in these species. Fluid warmers are essential for large volume resuscitation in all species to prevent hypothermia, which impairs coagulation and worsens shock. ## Documentation and Communication The resuscitation record should capture the time of each bolus, the volume administered, the delivery rate, and the reassessment findings. This documentation serves two purposes: it allows the clinician to track total volume and response over time, and it provides a clear record for transfer of care to another clinician or for medicolegal purposes. A structured resuscitation flow sheet is more useful than narrative notes. The flow sheet should include columns for time, bolus number, volume, rate, heart rate, blood pressure or perfusion parameters, lactate if measured, and the clinician's assessment of response. This format allows rapid identification of trends, such as a patient whose blood pressure improves with each bolus but whose lactate continues to rise, a pattern that suggests inadequate perfusion despite apparent hemodynamic stability. The following table summarizes the reassessment framework and the decision at each point: | Reassessment Finding | Interpretation | Next Action | |---|---|---| | Perfusion parameters normalized | Shock resolved | Stop boluses, transition to maintenance rate | | Improvement but incomplete | Partial response | Repeat bolus once, then reassess | | No change after two boluses | Non-responder | Stop crystalloid boluses, reassess diagnosis | | Worsening perfusion or respiratory signs | Volume overload or progression | Stop fluids, consider diuretics, vasopressors, or blood products | | Lactate rising despite stable perfusion | Ongoing ischemia or hemorrhage | Investigate source, consider blood products or surgery | The clinician should also document the total volume administered at each reassessment point and compare it against the ceiling for the patient's size and condition. This practice prevents the gradual accumulation of fluid that occurs when boluses are repeated without a clear stopping rule. ## Recognized Complications and Early Detection Fluid resuscitation failures typically present as one of three patterns: persistent hypoperfusion despite adequate volume, volume overload with tissue edema, or hemodynamic deterioration during administration. Each pattern has identifiable early markers. Persistent hypoperfusion is detected by failure of the chosen perfusion endpoints to normalize after the first bolus. Capillary refill time, lactate clearance, venous oxygen saturation, and urine output should be reassessed at the designated interval. A sublingual carbon dioxide measurement, where available, offers a sensitive perfusion target, in an experimental porcine model of hemorrhagic shock, resuscitation guided by sublingual PCO2 reduced total fluid requirements compared with blood pressure-guided therapy without compromising survival. The threshold used was initiation at a PCO2 above 70 Torr and cessation at 50 Torr. Volume overload manifests as chemosis, serous nasal discharge, tachypnoea, crackles on thoracic auscultation, or a rising central venous pressure. In small animal patients, serial body weight is the most sensitive bedside measure of net fluid retention. The 2024 AAHA/AAFP fluid therapy guidelines emphasize scheduled weight checks and explicit stopping criteria as core safeguards against iatrogenic hypervolaemia. Hemodynamic deterioration during a bolus, such as worsening hypotension or bradycardia, suggests either anaphylactoid reaction to the fluid or decompensation of an underlying cardiac lesion. Stop the bolus immediately and reassess perfusion and cardiac rhythm before resuming at a slower rate. ## Common Errors and Corrective Actions The most frequent error is treating the bolus as a fixed prescription instead of a physiological test. A bolus is a diagnostic intervention: the response, or lack of response, defines the next step. A second error is escalating fluid rate in a non-responder without first reassessing perfusion status, which risks converting hypovolemic shock into cardiogenic or distributive overload. Less experienced clinicians often confuse blood pressure with perfusion. Mean arterial pressure can be normal or elevated in early septic shock while tissue hypoxia persists. Conversely, a hypotensive patient with warm extremities and a rapid capillary refill time may have adequate perfusion despite a low pressure. The loading-dominant model of ventricular function in endotoxic shock supports this distinction: ejection fraction changes during resuscitation are driven primarily by loading conditions instead of contractility, so pressure-based titration alone misleads the clinician about true cardiac performance. A third error is failing to distinguish hemorrhagic from non-hemorrhagic shock before starting fluids. In confirmed or suspected hemorrhage, the resuscitation target should be permissive hypotension, not normotension, to avoid disrupting an immature clot. The AAHA/AAFP guidelines and the RECOVER post-arrest recommendations both caution against aggressive volume expansion in patients with ongoing bleeding. | Observation | Likely cause | Discriminating check | |---|---|---| | Lactate rises after initial improvement | Ongoing hemorrhage or occult hypoperfusion | Repeat perfusion assessment, consider imaging or invasive pressure monitoring | | Tachypnoea and crackles after bolus | Volume overload | Stop fluids, assess oxygenation, measure body weight trend | | Hypotension with normal or fast capillary refill | Distributive shock, not hypovolemia | Assess central venous oxygen saturation or lactate, consider vasopressor support | | Bradycardia during rapid bolus | Vagal response or cardiac decompensation | Stop bolus, ECG, reassess perfusion before resuming | | No change in perfusion after two boluses | Non-fluid-responsive shock | Reclassify shock type, consider inotrope or vasopressor, revisit diagnosis | ## Limitations of the Evidence and Divergent Expert Opinion The evidence base for resuscitation strategy is drawn heavily from experimental models and human trauma literature. Porcine hemorrhagic shock models have informed the concept of permissive hypotension and perfusion-guided titration, but direct translation to clinical veterinary patients is limited by species differences, the controlled nature of experimental hemorrhage, and the absence of large prospective veterinary trials. Colloid use remains contested. Experimental work in porcine hemorrhagic shock has shown that hydroxyethyl starch and gelatine solutions produce different cerebral inflammatory and perfusion profiles compared with balanced electrolyte solutions, but the clinical significance of these differences is uncertain. The AAHA/AAFP guidelines currently recommend crystalloids as first-line resuscitation fluids in dogs and cats, with colloids reserved for specific indications. Expert opinion diverges on the role of vasopressin in hemorrhagic shock. Arginine vasopressin has been proposed as an adjunct to reduce fluid requirements and support perfusion pressure, and experimental and limited human data suggest benefit, but no large prospective veterinary studies exist to define its place in the resuscitation protocol. ## Referral, Consultation, and Reporting Referral to a specialist critical care service is warranted when a patient fails to respond to two structured boluses, when shock recurs after initial stabilization, or when the clinician suspects a non-fluid-responsive mechanism such as pericardial effusion, pulmonary thromboembolism, or severe myocardial dysfunction. Specialist consultation is also appropriate before initiating advanced hemodynamic monitoring such as arterial catheterization, central venous catheterization, or transpulmonary thermodilution. Laboratory involvement is indicated for serial lactate measurement, blood gas analysis, coagulation profiling in suspected hemorrhagic shock, and blood culture in septic patients before antimicrobial administration. The MSD Veterinary Manual provides species-specific reference intervals and interpretive guidance for these parameters. Regulatory reporting obligations vary by jurisdiction. Reportable conditions include notifiable diseases presenting with shock, such as anthrax or hemorrhagic fevers, and suspected adverse reactions to veterinary medicinal products. The World Organization for Animal Health terrestrial animal health standards define international reporting requirements for listed diseases, and the AVMA practice resources summarize US-specific obligations. Clinicians should confirm the requirements of their local regulatory authority before initiating treatment in any shock patient with a potentially notifiable differential diagnosis. ## Frequently Asked Questions ### How Do I Adjust Resuscitation Strategy When Advanced Monitoring Is Unavailable? When invasive monitoring or point-of-care ultrasound is not available, rely on serial physical examination and basic vital parameters. Mucous membrane color, capillary refill time, heart rate, pulse quality, and serial lactate measurement, where a bench-top analyzer exists, provide sufficient trend data for most resuscitation decisions. The [AAHA/AAFP fluid therapy guidelines](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/) emphasize structured bolus delivery with mandatory reassessment after each bolus, which does not require advanced equipment. Blood pressure measurement with a Doppler or oscillometric device strengthens decision-making considerably. If even that is unavailable, extend the reassessment interval and use smaller individual boluses to reduce the risk of unrecognised over-resuscitation. Document the monitoring limitations explicitly in the medical record so that subsequent clinicians understand the confidence level of the resuscitation endpoints used. ### What Is the Role of Vasopressors During Fluid Resuscitation in Shock? Vasopressors are not a substitute for volume restoration but become necessary when perfusion targets cannot be achieved despite adequate fluid administration, or when fluid therapy risks worsening pulmonary edema or abdominal compartment syndrome. In hemorrhagic shock, arginine vasopressin has been investigated as an adjunct that may minimize ongoing blood loss while supporting perfusion pressure, though large prospective clinical trials are lacking and current guidance rests on experimental and limited human data, as summarized in [a review of vasopressin in hemorrhagic shock](https://pubmed.ncbi.nlm.nih.gov/22480832/). In endotoxic shock, norepinephrine is commonly used after fluid resuscitation, and recent work in a porcine model demonstrates that ejection fraction changes during resuscitation are determined primarily by loading conditions instead of contractility, supporting the rationale for vasopressor support to optimize afterload once preload is addressed. Consult current formulary references for species-specific dosing and administration protocols. ### How Should I Manage Fluid Resuscitation When Financial or Supply Constraints Limit Care? When ideal resources are unavailable, prioritize the minimum effective resuscitation instead of maximal therapy. Balanced crystalloids are generally the most cost-effective first-line choice. Smaller, more frequent boluses with careful reassessment reduce total fluid consumption compared with large empirical volumes. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides guidance on basic monitoring that can be performed with minimal equipment. If synthetic colloids are unaffordable, they are not required for most shock resuscitation. For production animals, consider the economic value of the patient relative to treatment cost and prognosis, and discuss this transparently with the owner. When blood products are unavailable for hemorrhagic shock, permissive hypotension with crystalloid support may be preferable to aggressive volume loading, as excessive crystalloid administration can worsen hemorrhage by disrupting clot formation. ### How Does Resuscitation Strategy Differ in Neonatal or Pediatric Patients? Neonates and pediatric patients have higher baseline fluid requirements per kilogram, reduced hepatic and renal clearance of drugs, and limited glycogen reserves, but their cardiovascular compliance differs from adults. The [AAHA/AAFP fluid therapy guidelines](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/) recommend smaller individual boluses, typically delivered over longer infusion times, with more frequent reassessment in pediatric patients. Hypoglycemia and hypothermia complicate shock in neonates and should be addressed concurrently. Jugular venous distension and hepatomegaly are important early indicators of volume overload in puppies and kittens. For neonatal ruminants and foals, partial failure of passive transfer increases infection risk, so resuscitation should be paired with appropriate diagnostic investigation for sepsis. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) offers species-specific guidance on pediatric fluid therapy and monitoring. ### What Should I Document in the Medical Record During a Resuscitation Event? Document the initial perfusion assessment, the suspected shock category, and the specific endpoints chosen before starting therapy. Record each bolus with time, volume, fluid type, route, and the reassessment findings that followed. Note any decision points where the protocol changed and the clinical rationale for that change. The [AVMA practice resources](https://www.avma.org/resources-tools) emphasize that contemporaneous records of emergency interventions support continuity of care and defensible medical decision-making. Include vital parameters at each reassessment, cumulative fluid totals, urine output where measured, and any complications observed. If monitoring was limited by equipment availability, document that limitation. Finally, record the response to therapy in terms of the original endpoints, also a global impression, so that subsequent clinicians can judge whether resuscitation goals were actually achieved. ### How Do I Explain Resuscitation Failure to an Owner or Referring Veterinarian? Use clear language that distinguishes between the shock process and the response to treatment. Explain that fluid resuscitation is the first step, but that some patients do not stabilize despite appropriate therapy, and that this may reflect the severity of the underlying disease, ongoing losses, or cardiovascular failure that fluids alone cannot correct. Reference the [RECOVER Initiative guidelines](https://recoverinitiative.org/) when discussing the transition from resuscitation to ongoing stabilization or rescue therapies, as these guidelines provide a structured framework for escalation of care. Be honest about prognosis without being fatalistic. Offer the owner a concrete plan for the next hours, including what monitoring will be performed and what criteria would trigger a change in approach. For referring veterinarians, provide a written summary of fluids administered, response to each bolus, and current perfusion status to support seamless transfer of care. ## Related Clinical & Scientific Guides * [Toxicology in Emergency Practice: Common Poisons and Diagnostic Approach](/knowledge/veterinary-medicine/emergency-critical-care/toxicology-emergency-practice-common-poisons-diagnostic-approach) * [Veterinary Cardiopulmonary Resuscitation: Post-Cardiac Arrest Care](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-cardiopulmonary-resuscitation-post-cardiac-arrest-care) * [Fluid Therapy Guidelines for Dogs and Cats: A Practical Update](/knowledge/veterinary-medicine/emergency-critical-care/fluid-therapy-guidelines-dogs-cats-practical-update) ## References and Further Reading - [Fluid resuscitation guided by sublingual partial pressure of carbon dioxide during hemorrhagic shock in a porcine model.](https://pubmed.ncbi.nlm.nih.gov/23364438/). 2013. - [Arginine vasopressin: the future of pressure-support resuscitation in hemorrhagic shock.](https://pubmed.ncbi.nlm.nih.gov/22480832/). 2012. - [Effect of fluid resuscitation on cerebral integrity: A prospective randomised porcine study of hemorrhagic shock.](https://pubmed.ncbi.nlm.nih.gov/33399378/). 2021. - [Loading conditions instead of contractility primarily determine biventricular ejection fraction in endotoxic shock.](https://pubmed.ncbi.nlm.nih.gov/42518262/). 2026. - [RECOVER Initiative Veterinary CPR Guidelines](https://recoverinitiative.org/). Veterinary Emergency and Critical Care Society. - [AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats](https://www.aaha.org/resources/2024-aaha-fluid-therapy-guidelines-for-dogs-and-cats/). AAHA. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. - [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association. - [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). WOAH. ## Related Articles - [Goal-Directed Fluid Therapy in Sepsis: Resuscitation, Optimization, and Maintenance](/knowledge/veterinary-medicine/emergency-critical-care/goal-directed-fluid-therapy-sepsis-resuscitation-optimization-maintenance) - [Veterinary Fluid Therapy: Crystalloids vs Colloids](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-fluid-therapy-crystalloids-colloids) - [Veterinary Shock: Compensatory Mechanisms and Progression](/knowledge/veterinary-medicine/emergency-critical-care/veterinary-shock-compensatory-mechanisms-progression) - [Point-of-Care Ultrasound in Veterinary Shock Assessment](/knowledge/veterinary-medicine/emergency-critical-care/point-of-care-ultrasound-veterinary-shock-assessment) - [Shock Wave Therapy in Veterinary Medicine: Mechanisms and Clinical Use](/knowledge/veterinary-medicine/emergency-critical-care/shock-wave-therapy-veterinary-medicine-mechanisms-clinical-use) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.